“Adjuvanted Intranasal Norwalk Virus-Like Particle Vaccine Elicits Antibodies and Antibody-Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues”, J Infect Dis, vol. 202, pp. 1648-1658, 2010.
, “Comparison of the Immunogenicity and Safety of a Split-Virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal and Intramuscular Route in Healthy Adults”, Vaccine, vol. 29, pp. 5666-5674, 2011.
, “Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.”, J Infect Dis, vol. 181, no. 2, pp. 725-8, 2000.
, “Comparison of the safety, vaccine virus shedding and immunogenicity of influenza virus vaccine, trivalent, types A and B, live-cold-adapted (LAIV) administered to HIV-infected and non-HIV-infected adults”, J Infec Dis, vol. 181, pp. 725-8, 2000.
, “Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine”, J Infec Dis, vol. 181, pp. 11133-7, 2000.
, “Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.”, J Infect Dis, vol. 181, no. 3, pp. 1133-7, 2000.
, “The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children”, N Engl J Med, vol. 338, pp. 1405-12, 1998.
, “The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.”, N Engl J Med, vol. 338, no. 20, pp. 1405-12, 1998.
, “Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.”, J Pediatr, vol. 136, no. 2, pp. 168-75, 2000.
, “Efficacy of Vaccination with Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine Against a Variant (A/Sidney) not Contained in the Vaccine”, J Pediatric, vol. 136, pp. 168-175, 2000.
, “Evaluation of a Single Dose of Half Strength Inactivated Influenza Vaccine in Healthy Adults”, Vaccine, vol. 20, pp. 1099-1105, 2002.
, “Mercury Levels in Newborns and Infants after Receipt of Thimerosal-Containing Vaccines”, Pediatrics, vol. 121, pp. e208-e214, 2008.
, “Norovirus Vaccine Against Experimental Human GII.4 Virus Illness: A Challenge Study in Healthy Adults”, J Infect Dis, vol. jiu497 [pi, 2014.
,